Phase 1. Phase 2. Phase 3. Anti-Integrin Portfolio. CRB-601. Anti-αvβ8 mAb. Solid Tumors ... TGF-β in T Cell Biology: Implications for Cancer Immunotherapy.
確定! 回上一頁